Species identification after treatment for human taeniasis

Cesar Jeri, Robert H Gilman, Andres G. Lescano, Holger Mayta, Maria E. Ramirez, Armandoe Gonzalez, Rahim Nazerali, Hector H. Garcia

Research output: Contribution to journalArticle

Abstract

Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.

Original languageEnglish (US)
Pages (from-to)949-950
Number of pages2
JournalThe Lancet
Volume363
Issue number9413
DOIs
StatePublished - Mar 20 2004
Externally publishedYes

Fingerprint

Taeniasis
Electrolytes
Salts
Cestoda
Taenia
Niclosamide
Taenia solium
Cathartics
Castor Oil
Forensic Anthropology
Eggs
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jeri, C., Gilman, R. H., Lescano, A. G., Mayta, H., Ramirez, M. E., Gonzalez, A., ... Garcia, H. H. (2004). Species identification after treatment for human taeniasis. The Lancet, 363(9413), 949-950. https://doi.org/10.1016/S0140-6736(04)15791-7

Species identification after treatment for human taeniasis. / Jeri, Cesar; Gilman, Robert H; Lescano, Andres G.; Mayta, Holger; Ramirez, Maria E.; Gonzalez, Armandoe; Nazerali, Rahim; Garcia, Hector H.

In: The Lancet, Vol. 363, No. 9413, 20.03.2004, p. 949-950.

Research output: Contribution to journalArticle

Jeri, C, Gilman, RH, Lescano, AG, Mayta, H, Ramirez, ME, Gonzalez, A, Nazerali, R & Garcia, HH 2004, 'Species identification after treatment for human taeniasis', The Lancet, vol. 363, no. 9413, pp. 949-950. https://doi.org/10.1016/S0140-6736(04)15791-7
Jeri, Cesar ; Gilman, Robert H ; Lescano, Andres G. ; Mayta, Holger ; Ramirez, Maria E. ; Gonzalez, Armandoe ; Nazerali, Rahim ; Garcia, Hector H. / Species identification after treatment for human taeniasis. In: The Lancet. 2004 ; Vol. 363, No. 9413. pp. 949-950.
@article{7bf963f04a274ebd8ae87a84aa4b9e44,
title = "Species identification after treatment for human taeniasis",
abstract = "Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62{\%}) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.",
author = "Cesar Jeri and Gilman, {Robert H} and Lescano, {Andres G.} and Holger Mayta and Ramirez, {Maria E.} and Armandoe Gonzalez and Rahim Nazerali and Garcia, {Hector H.}",
year = "2004",
month = "3",
day = "20",
doi = "10.1016/S0140-6736(04)15791-7",
language = "English (US)",
volume = "363",
pages = "949--950",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9413",

}

TY - JOUR

T1 - Species identification after treatment for human taeniasis

AU - Jeri, Cesar

AU - Gilman, Robert H

AU - Lescano, Andres G.

AU - Mayta, Holger

AU - Ramirez, Maria E.

AU - Gonzalez, Armandoe

AU - Nazerali, Rahim

AU - Garcia, Hector H.

PY - 2004/3/20

Y1 - 2004/3/20

N2 - Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.

AB - Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.

UR - http://www.scopus.com/inward/record.url?scp=1642291632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642291632&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(04)15791-7

DO - 10.1016/S0140-6736(04)15791-7

M3 - Article

C2 - 15043964

AN - SCOPUS:1642291632

VL - 363

SP - 949

EP - 950

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9413

ER -